A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11.beta.-hydroxysteroid dehydrogenase type 1 (11.beta.HSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome.

 
Web www.patentalert.com

< Aminoalkylphosphonates and related compounds as edg receptor agonists

< Estrogen replacement regimen

> Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators

> Novel compounds and compositions as cathepsin inhibitors

~ 00257